Home » Topics » Conferences

Conferences
RSS

Potent and selective dopamine D4 antagonist discovered at Yamanouchi

Dec. 11, 1997

Preclinical and preliminary clinical profile of NE-100, a new antipsychotic drug

Dec. 11, 1997

E-5531: a synthetic endotoxin antagonist developed at Eisai

Dec. 11, 1997

Novel antithrombotic agent developed at Otsuka

Dec. 11, 1997

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

Preclinical toxicity profile of ISIS-2503

Dec. 9, 1997

Safe and effective new D2 partial agonist in development at Wyeth-Ayerst

Dec. 9, 1997

AMPA antagonist investigated for treatment of drug withdrawal

Dec. 9, 1997

Novel valproic acid prodrug reported at scientific meeting

Dec. 9, 1997

New antihyperalgesic agents from Adolor

Dec. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...